Genomic medicine in the prevention and treatment of atherosclerotic cardiovascular disease

Personalized Medicine
Sony Tuteja, Daniel J Rader

Abstract

Cardiovascular disease (CVD) is the leading cause of death in the world. Over the past decade considerable progress has been made in understanding the genomic basis of polygenic disorders including CVD. The future application of genomic medicine to the prevention and treatment of CVDs will ultimately lessen the burden of CVD. Given the complex nature of CVD, information derived from newer evolving fields, such as transcriptomics, proteomics and metabolomics, will allow us to fully interrogate features of the human genome to better understand disease pathogenesis and to identify new drug targets. In this article, we will review how genomics will allow enhanced risk prediction of cardiovascular events, provide personalized treatment options and hasten the drug development process, with a particular focus on atherosclerotic CVD.

References

Apr 14, 1994·The New England Journal of Medicine·M E MarenbergU de Faire
May 29, 1998·Circulation·P W WilsonW B Kannel
Feb 7, 2003·The New England Journal of Medicine·Richard Weinshilboum
Apr 4, 2003·JAMA : the Journal of the American Medical Association·Paul D ThompsonRichard H Karas
May 2, 2003·Pharmacogenetics·Ann K Daly, Barry P King
Feb 7, 2004·Nature·Tao LiDarrel W Stafford
Apr 13, 2004·International Journal of Epidemiology·George Davey Smith, Shah Ebrahim
Jun 3, 2005·The New England Journal of Medicine·Mark J RiederAllan E Rettie
Mar 24, 2006·The New England Journal of Medicine·Jonathan C CohenHelen H Hobbs
Apr 10, 2007·Journal of the American College of Cardiology·Dominick J AngiolilloMarco A Costa
Apr 20, 2007·American Journal of Epidemiology·Alanna C MorrisonEric Boerwinkle
May 5, 2007·Science·Anna HelgadottirKari Stefansson
May 5, 2007·Science·Ruth McPhersonJonathan C Cohen
Jul 20, 2007·The New England Journal of Medicine·Nilesh J SamaniUNKNOWN WTCCC and the Cardiogenics Consortium
Sep 26, 2007·Nature Clinical Practice. Cardiovascular Medicine·Iftikhar J Kullo, Keyue Ding
Feb 29, 2008·Clinical Pharmacology and Therapeutics·B F GageH L McLeod
Mar 21, 2008·The New England Journal of Medicine·Sekar KathiresanMarju Orho-Melander
Jul 25, 2008·The New England Journal of Medicine·UNKNOWN SEARCH Collaborative GroupR Collins
Aug 30, 2008·Drugs in R&D·David S Wishart
Oct 31, 2008·The New England Journal of Medicine·Jeppe ZachoBørge G Nordestgaard
Feb 10, 2009·Nature Genetics·UNKNOWN Myocardial Infarction Genetics ConsortiumDavid Altshuler
Feb 10, 2009·Nature Genetics·Daniel F GudbjartssonKari Stefansson
Feb 10, 2009·Nature Genetics·Jeanette ErdmannHeribert Schunkert
Feb 21, 2009·The New England Journal of Medicine·UNKNOWN International Warfarin Pharmacogenetics ConsortiumJ A Johnson
Jul 23, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Oct 17, 2009·Journal of the American College of Cardiology·Deepak VooraGeoffrey S Ginsburg
Dec 19, 2009·Circulation·UNKNOWN WRITING GROUP MEMBERSUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Oct 1, 2008·Circulation. Cardiovascular Genetics·James A WingroveWilliam E Kraus
Dec 25, 2009·The New England Journal of Medicine·Robert ClarkeUNKNOWN PROCARDIS Consortium
Jan 15, 2010·Clinical Pharmacology and Therapeutics·L H CavallariJ A Johnson
Mar 31, 2010·Pharmacogenomics·Vangelis G ManolopoulosAnna Tavridou
Aug 6, 2010·Nature·Tanya M TeslovichSekar Kathiresan

❮ Previous
Next ❯

Citations

Mar 13, 2015·Proteomics. Clinical Applications·Paul Cutler, Hans Voshol

❮ Previous
Next ❯

Methods Mentioned

BETA
chip
genotyping
pharmacotherapy
nuclear magnetic resonance
exome sequencing

Software Mentioned

PLATO
CURE

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.